We are live on
!
Find out more
BA
Bridgewater Advisors Portfolio holdings
AUM
$1.83B
1-Year Est. Return
22.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+22.9%
3 Year Est. Return
+61.02%
5 Year Est. Return
+71.76%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$20M
(+20%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
234.77%
Top 10 Holdings %
Top 10 Hldgs %
40.12%
Holding
106
New
13
Increased
20
Reduced
31
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$266M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$5.13M |
| 3 |
Invesco S&P 500 Pure Growth ETF
RPG
|
+$5.06M |
| 4 |
Colgate-Palmolive
CL
|
+$4.38M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.93M |
| 2 |
AGN
Allergan Inc
AGN
|
+$1.73M |
| 3 |
Bunge Global
BG
|
+$1.32M |
| 4 |
Seaboard Corp
SEB
|
+$1.08M |
| 5 |
Citigroup
C
|
+$275K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 12.66% |
| 2 | Energy | 10.17% |
| 3 | Healthcare | 7.51% |
| 4 | Technology | 7.19% |
| 5 | Financials | 7.17% |
Similar funds
KAM
OQS
RP
SI
ABTD
FCIM
CPSAC
OFS
Bridgewater Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, Bridgewater Advisors held 106 positions worth $119M, up 20% from $99.4M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Bridgewater Advisors deployed $281M of net new capital in Q2 2014, opening 13 new positions and adding to 20 existing holdings. Its largest new stake was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.
By sector, the portfolio is most concentrated in Consumer Staples at 13% of assets, up from 12% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $1.93M trimmed.
- Bridgewater Advisors's largest Q2 2014 buy was Invesco S&P 500 Pure Value ETF: 97,590 shares worth $5.3M.
- Bridgewater Advisors added most to Berkshire Hathaway Class A in Q2 2014, an estimated $266M increase.
- Bridgewater Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.93M.
- Bridgewater Advisors fully exited Allergan Inc in Q2 2014, selling an estimated $1.73M.
- Bridgewater Advisors's ten largest holdings make up 40% of its $119M portfolio in Q2 2014.
- Bridgewater Advisors opened 13 new positions and closed 8 in Q2 2014.
- Bridgewater Advisors's portfolio value rose 20% quarter-over-quarter to $119M.
Based on Bridgewater Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.